Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

370 ARTÍCULOS , VIENDO DEL 301 AL 315

BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease

Prati F, Bottegoni G, Bolognesi ML, Cavalli A.

J Med Chem. 2018 Feb 8;61(3):619-637. doi: 10.1021/acs.jmedchem.7b00393. Epub 2017 Aug 8.

Three-Dimensional Models of the Human Brain Development and Diseases

Jorfi M, D'Avanzo C, Kim DY, Irimia D.

Adv Healthc Mater. 2018 Jan;7(1):10.1002/adhm.201700723. doi: 10.1002/adhm.201700723. Epub 2017 Aug 28.

Modulation of γ- and β-Secretases as Early Prevention Against Alzheimer's Disease

Voytyuk I, De Strooper B, Chávez-Gutiérrez L.

Biol Psychiatry. 2018 Feb 15;83(4):320-327. doi: 10.1016/j.biopsych.2017.08.001. Epub 2017 Aug 10.

Therapeutic peptides for CNS indications: Progress and challenges

Morimoto BH.

Bioorg Med Chem. 2018 Jun 1;26(10):2859-2862. doi: 10.1016/j.bmc.2017.09.011. Epub 2017 Sep 9.

Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise

van Dyck CH.

Biol Psychiatry. 2018 Feb 15;83(4):311-319. doi: 10.1016/j.biopsych.2017.08.010. Epub 2017 Aug 24.

Acetylcholinesterase Inhibitors: Beneficial Effects on Comorbidities in Patients With Alzheimer's Disease

Kaushik V, Smith ST, Mikobi E, Raji MA.

Am J Alzheimers Dis Other Demen. 2018 Mar;33(2):73-85. doi: 10.1177/1533317517734352. Epub 2017 Oct 3.

Curcumin or bisdemethoxycurcumin for nose-to-brain treatment of Alzheimer disease? A bio/chemo-informatics case study

Hathout RM, El-Ahmady SH, Metwally AA.

Nat Prod Res. 2018 Dec;32(24):2873-2881. doi: 10.1080/14786419.2017.1385017. Epub 2017 Oct 12.

How efficient are rodent models for Alzheimer's disease drug discovery?

Guo B, Zhou Q.

Expert Opin Drug Discov. 2018 Feb;13(2):113-115. doi: 10.1080/17460441.2018.1398730. Epub 2017 Oct 31.

A very low dose of rivastigmine-induced Pisa syndrome in a clozapine-treated patient

Chao PC, Li JC, Yeh TC, Yeh CB.

Aust N Z J Psychiatry. 2018 Feb;52(2):204-205. doi: 10.1177/0004867417741983. Epub 2017 Nov 9.

Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer's Disease: Systematic Review and Network Metaanalysis

Tricco AC, Ashoor HM, Soobiah C, Rios P, Veroniki AA, Hamid JS, Ivory JD, Khan PA, Yazdi F, Ghassemi M, Blondal E, Ho JM, Ng CH, Hemmelgarn B, Majumdar SR, Perrier L, Straus SE.

J Am Geriatr Soc. 2018 Jan;66(1):170-178. doi: 10.1111/jgs.15069. Epub 2017 Sep 29.

Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease

Kurochkin IV, Guarnera E, Berezovsky IN.

Trends Pharmacol Sci. 2018 Jan;39(1):49-58. doi: 10.1016/j.tips.2017.10.008. Epub 2017 Nov 10.

Caregiver burden regarding elderly with bipolar disorder: An underrecognized problem

Santos GD, Ladeira RB, Almeida JG, Aprahamian I, Forlenza OV, Lafer B, Nunes PV.

Gen Hosp Psychiatry. 2018 Mar-Apr;51:134-135. doi: 10.1016/j.genhosppsych.2017.10.011. Epub 2017 Nov 7.

A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia

Renn BN, Asghar-Ali AA, Thielke S, Catic A, Martini SR, Mitchell BG, Kunik ME.

Am J Geriatr Psychiatry. 2018 Feb;26(2):134-147. doi: 10.1016/j.jagp.2017.09.027. Epub 2017 Oct 10.

Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease

Seo EJ, Fischer N, Efferth T.

Pharmacol Res. 2018 Mar;129:262-273. doi: 10.1016/j.phrs.2017.11.030. Epub 2017 Nov 24.

Intranasal insulin in Alzheimer's disease: Food for thought

Chapman CD, Schiöth HB, Grillo CA, Benedict C.

Neuropharmacology. 2018 Jul 1;136(Pt B):196-201. doi: 10.1016/j.neuropharm.2017.11.037. Epub 2017 Nov 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias